Regulation of MDR-1 (P-glycoprotein) by cyclooxygenase-2 - Wikidata - wikimedia - TriplyDB

Regulation of MDR-1 (P-glycoprotein) by cyclooxygenase-2

Regulation of MDR-1 (P-glycoprotein) by cyclooxygenase-2

http://www.wikidata.org/entity/Q28573372

about

Relationship between the expression of cyclooxygenase 2 and MDR1/P-glycoprotein in invasive breast cancers and their prognostic significance Non steroidal anti-inflammatory drugs and COX-2 inhibitors as anti-cancer therapeutics: hypes, hopes and reality Inherent and acquired resistance to paclitaxel in hepatocellular carcinoma: molecular events involved Murine P-glycoprotein deficiency alters intestinal injury repair and blunts lipopolysaccharide-induced radioprotection.CCAAT/enhancer-binding proteins (C/EBP)-α and -β are essential for ovulation, luteinization, and the expression of key target genes Polymorphisms in the xenobiotic transporter Multidrug Resistance 1 (MDR1) and interaction with meat intake in relation to risk of colorectal cancer in a Danish prospective case-cohort study Comparing the use of Affymetrix to spotted oligonucleotide microarrays using two retinal pigment epithelium cell lines Doxorubicin combined with celecoxib inhibits tumor growth of medullary thyroid carcinoma in xenografted mice The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies.MDR1A deficiency restrains tumor growth in murine colitis-associated carcinogenesis Targeting 20-HETE producing enzymes in cancer - rationale, pharmacology, and clinical potential Effect of prostaglandin E2 on multidrug resistance transporters in human placental cells.COX-2 inhibition in cancer therapeutics: a field of controversy or a magic bullet?TLR4 signaling promotes a COX-2/PGE2/STAT3 positive feedback loop in hepatocellular carcinoma (HCC) cells.Regulation of multidrug resistance 1 expression by CDX2 in ovarian mucinous adenocarcinoma.What is New on Thyroid Cancer Biomarkers Resveratrol reverses P-glycoprotein-mediated multidrug resistance of U2OS/ADR cells by suppressing the activation of the NF-κB and p38 MAPK signaling pathways.Eicosanoids in inflammation and cancer: the role of COX-2.Potency of non-steroidal anti-inflammatory drugs in chemotherapy.Celecoxib enhances anticancer effect of cisplatin and induces anoikis in osteosarcoma via PI3K/Akt pathway.Repurposing drugs for treatment of tuberculosis: a role for non-steroidal anti-inflammatory drugs.Melatonin-mediated Bim up-regulation and cyclooxygenase-2 (COX-2) down-regulation enhances tunicamycin-induced apoptosis in MDA-MB-231 cells.Mitochondria of a human multidrug-resistant hepatocellular carcinoma cell line constitutively express inducible nitric oxide synthase in the inner membrane.Pseudolaric acid B circumvents multidrug resistance phenotype in human gastric cancer SGC7901/ADR cells by downregulating Cox-2 and P-gp expression.The interaction of celecoxib with MDR transporters enhances the activity of mitomycin C in a bladder cancer cell line.Non-Steroidal Anti-inflammatory Drugs As Host-Directed Therapy for Tuberculosis: A Systematic Review.Regulation of the apoptosis-inducing kinase DRAK2 by cyclooxygenase-2 in colorectal cancer.Suppression of P-glycoprotein gene expression in Hs578T/Dox by the overexpression of caveolin-1.Immunohistochemical expression of potential therapeutic targets in canine thyroid carcinoma.Cellular signaling pathway alterations and potential targeted therapies for medullary thyroid carcinoma.Inhibition of bacterial multidrug resistance by celecoxib, a cyclooxygenase-2 inhibitor.YAP transcriptionally regulates COX-2 expression and GCCSysm-4 (G-4), a dual YAP/COX-2 inhibitor, overcomes drug resistance in colorectal cancer.Cyclooxygenases in hepatocellular carcinoma.Celecoxib Up Regulates the Expression of Drug Efflux Transporter ABCG2 in Breast Cancer Cell Lines.Effects of nonsteroidal anti-inflammatory drugs on the expression and function of P-glycoprotein/MDR1 in Caco-2 cells.Cyclooxygenase-2 inhibits tumor necrosis factor alpha-mediated apoptosis in renal glomerular mesangial cells.Cyclooxygenase-2 in oligodendroglioma: possible prognostic significance.Significance of COX-2 and VEGF expression in histopathologic grading and invasiveness of meningiomas.Altered P-glycoprotein expression in AIDS patients with HIV encephalitis.Novel strategies to prevent the development of multidrug resistance (MDR) in cancer.

P2860

Q24813854-337D76BB-0BA5-4924-A91C-B8AA7CBD1955 Q28166312-2DF9ACFA-9B53-46DB-9359-A218A5E6CF06 Q28486233-55E4A022-F17D-4132-AF53-7697AABBDDB8 Q30417497-2DAF6DE2-5D96-4B84-9AAD-9A148A514AC4 Q30426060-CD1BC519-7ACF-4A6C-8368-3EC342FACC0E Q30907350-027DCCFF-40F2-4190-8173-85F39C33F318 Q33641073-D74C2EBA-D809-4C68-AAA2-326A76BDCC95 Q33727633-BDCD014A-BB81-464F-9837-3F8C425D3FC1 Q33737469-7D6E088C-D710-4F1E-84F3-6BB819AC99B7 Q33884295-F7FC2CBD-8404-4D84-9256-64ED1331D372 Q34338086-1C946F39-4D6E-4BA4-9C37-76D6204B591D Q34575038-15C5E037-99C0-4129-AD87-CD6F106A0DAA Q35753467-3D4A1BA5-1196-4D33-A924-0F4B2D204C7C Q36710952-63B550AA-F42E-4C54-A758-BC9A7E30FFCA Q37094927-838F3096-C00E-4324-8860-1AAFC1C786B8 Q37207279-610160D4-76F1-48D4-A5E1-29F53D9F26DF Q37407335-090EA563-665C-44A4-84BD-2AAF3260122A Q37754720-3DBB503C-DCD8-4FF4-9853-377117C073AC Q38282100-8FABC08E-2337-4991-AC93-12C1C42E03EA Q38722912-F8D1E5E6-A822-44A6-927B-482C328A51BC Q38827332-961BD651-9430-4D0B-B854-C4DE94F091F4 Q38906542-166256FB-214D-4C3F-8221-2F43AD7E3F64 Q38908584-D13E573C-2537-493A-B7E2-90928710DD61 Q38970159-3ADCC17E-2E28-4319-9AFD-9E65A8A9547B Q39147858-CAD8F211-E0D5-4DCF-B3B7-2E04959CBE28 Q39437994-912341DF-1AB7-46FE-B0C2-B43B72D9CE4D Q39819644-D9A28000-5538-418B-A9F8-7221795C8A21 Q40501410-CC7119D0-BA63-47E9-869D-BDAF4E68AC60 Q41055385-7EE369C6-7599-4FDF-9F90-722AD85CE6DA Q41251561-0AB4A27D-50C9-4C6F-AED6-97BB02EE8515 Q41970348-30E25DE4-8EB3-4082-B07C-D1F960EF8321 Q42690256-1FB7AC32-F851-4871-81AF-A3B537C02F57 Q42726279-0DEF3705-C002-47B5-B3DB-CA87ED71275F Q43007158-813239B1-E2DA-4608-A2F2-B89D0F4FAA83 Q43269139-2741E413-6AAC-4F6C-A1CC-05932B8DAD5F Q44269055-65385280-C0F4-4CEC-AFB6-BCBEF70B1726 Q45106767-A3BE5569-02EC-4E15-A3F2-6E0D822A190D Q46649981-779A145C-67A8-41E1-9D4E-E89F3C063F98 Q46966972-39C3F649-A9DE-4519-AFB8-BC1FCBDD5699 Q47129596-7234D4B2-68B9-4967-A866-F99A738372C7

P2860

Regulation of MDR-1 (P-glycoprotein) by cyclooxygenase-2

http://www.wikidata.org/entity/Q28573372

description

2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

article publié dans la revue scientifique Journal of Biological Chemistry

@fr

artículu científicu espublizáu en 2002

@ast

im Oktober 2002 veröffentlichter wissenschaftlicher Artikel

@de

scientific journal article

@en

vedecký článok (publikovaný 2002/10/11)

@sk

vědecký článek publikovaný v roce 2002

@cs

wetenschappelijk artikel (gepubliceerd op 2002/10/11)

@nl

наукова стаття, опублікована в жовтні 2002

@uk

name

Regulation of MDR-1 (P-glycoprotein) by cyclooxygenase-2

@ast

Regulation of MDR-1 (P-glycoprotein) by cyclooxygenase-2

@en

Regulation of MDR-1 (P-glycoprotein) by cyclooxygenase-2

@nl

type

label

Regulation of MDR-1 (P-glycoprotein) by cyclooxygenase-2

@ast

Regulation of MDR-1 (P-glycoprotein) by cyclooxygenase-2

@en

Regulation of MDR-1 (P-glycoprotein) by cyclooxygenase-2

@nl

prefLabel

Regulation of MDR-1 (P-glycoprotein) by cyclooxygenase-2

@ast

Regulation of MDR-1 (P-glycoprotein) by cyclooxygenase-2

@en

Regulation of MDR-1 (P-glycoprotein) by cyclooxygenase-2

@nl

P1433

Q28573372-67036F54-6845-45A9-A21E-CE876AFCEE8D

P1476

Q28573372-09ADD84B-C379-4D1C-9427-87CAF88C0C78

P2093

Q28573372-2B436139-7E30-47FC-A575-DDE06EC4688A

Q28573372-F9423459-16AF-435F-AAA5-8CF20C4A56CD

P2860

Q28573372-0D167C74-B5D3-4358-B671-47FF6B6F3E19

Q28573372-0EF7A698-994C-45F3-918B-A96DFAD3CA1C

Q28573372-0F3D29D0-0E32-45C9-9C67-96E494D5DE1E

Q28573372-288CF476-1525-4C59-B9E2-DA937C39109E

Q28573372-3545F38E-4ADE-4474-B146-6EA008BCF692

Q28573372-392E6CF3-E5E4-4AA4-8BE1-A521F5D4BE74

Q28573372-42B2A14D-009A-4CDE-B5F3-4E0C57F6BF70

Q28573372-9703376C-9740-4B2A-85C9-0A9E0B093620

Q28573372-A4D32111-665F-4DD0-9CC9-637ABF80AFCE

Q28573372-D45CF12C-E73B-4AEF-A9E4-359E9C7153E7

P304

Q28573372-9774B12C-40EA-421A-B159-FD275331E09C

P31

Q28573372-322F46CE-A1B9-4F3E-9D4E-291DECCFCAC4

P3181

Q28573372-C8D58336-4F44-4969-A395-A67057C64E3E

P356

Q28573372-100DA7D4-7F57-4F1C-A670-171D5CA77693

P407

Q28573372-41684B1D-7DDA-4776-8177-44614FCD6796

P433

Q28573372-37B9D0FC-4CAB-458E-8EA3-8938952F8CA6

P478

Q28573372-66ED3A98-7053-40CF-BF4A-84161F952D97

P50

Q28573372-43AEF702-E63A-4136-B086-6171ACBAA7E3

P577

Q28573372-B2AEFBCD-F2DB-47AE-A60C-8096A1D8330A

P698

Q28573372-C3E7B665-853D-4FFF-AFDA-A206B5304322

P3181

P356

P1433

Journal of Biological Chemistry

P1476

Regulation of MDR-1 (P-glycoprotein) by cyclooxygenase-2

@en

P2093

Michael J Dunn

http://www.w3.org/2001/XMLSchema#string

Vimal A Patel

http://www.w3.org/2001/XMLSchema#string

P2860

MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2

Up-regulation of multidrug resistance P-glycoprotein via nuclear factor-kappaB activation protects kidney proximal tubule cells from cadmium- and reactive oxygen species-induced apoptosis

Biochemistry of multidrug resistance mediated by the multidrug transporter

Cyclooxygenase-2 expression inhibits trophic withdrawal apoptosis in nerve growth factor-differentiated PC12 cells.

Cyclooxygenase 2 promotes cell survival by stimulation of dynein light chain expression and inhibition of neuronal nitric oxide synthase activity.

Multiple physiological functions for multidrug transporter P-glycoprotein?

Intracellular unesterified arachidonic acid signals apoptosis.

P304

38915-38920

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2450282

http://www.w3.org/2001/XMLSchema#string

P356

10.1074/JBC.M206855200

http://www.w3.org/2001/XMLSchema#string

P407

P433

41

http://www.w3.org/2001/XMLSchema#string

P478

277

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-07-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12138126

http://www.w3.org/2001/XMLSchema#string